BioCentury
ARTICLE | Company News

FDA panel to discuss Pfizer's Xeljanz in UC

January 19, 2018 9:34 PM UTC

FDA's Gastrointestinal Drugs Advisory Committee will meet on March 8 to discuss an sNDA from Pfizer Inc. (NYSE:PFE) for Xeljanz tofacitinib tablets to treat adults with moderate to severe active ulcerative colitis. ...

BCIQ Company Profiles

Pfizer Inc.